These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7438973)
1. Developmental outcome of premature infants treated with theophylline. Nelson RM; Resnick MB; Holstrum WJ; Eitzman DV Dev Pharmacol Ther; 1980; 1(5):274-80. PubMed ID: 7438973 [TBL] [Abstract][Full Text] [Related]
2. [Hyponatremia and theophylline in very low birthweight premature infants]. Sann L; Cottancin G; Bourgeois J; Bory C; Baltassat P; Bethenod M Arch Fr Pediatr; 1982; 39(7):419-22. PubMed ID: 7149887 [TBL] [Abstract][Full Text] [Related]
3. [Preventive treatment with theophylline of apnea in premature infants: clinical, pharmokinetic and neurophysiological study]. Demarquez JL; Brachet-Lierman A; Paty J; Deliac MM; Philippe JC; Maix M; Babin JP; Martin C Arch Fr Pediatr; 1978; 35(7):793-805. PubMed ID: 736736 [TBL] [Abstract][Full Text] [Related]
4. [Apnea and theophylline in the premature infant. Clinical and pharmacokinetic study in 32 premature infants]. Cottancin G; Sann L; Bory B; Bourgeois J; Frederich A; Baltassat P; Bethenod M Pediatrie; 1981 Mar; 36(2):91-101. PubMed ID: 7232073 [No Abstract] [Full Text] [Related]
5. Treatment of severe apnea in prematures with orally administered theophylline. Uauy R; Shapiro DL; Smith B; Warshaw JB Pediatrics; 1975 May; 55(5):595-8. PubMed ID: 1128984 [TBL] [Abstract][Full Text] [Related]
6. Factors affecting theophylline pharmacokinetics in premature infants with apnea. Hilligoss DM; Jusko WJ; Koup JR; Giacoia G Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline]. Alix D; Berthou F; Riche C; Gouedard H Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680 [TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity. Al-Saif S; Alvaro R; Manfreda J; Kwiatkowski K; Cates D; Qurashi M; Rigatto H J Pediatr; 2008 Oct; 153(4):513-8. PubMed ID: 18534618 [TBL] [Abstract][Full Text] [Related]
9. T4 levels in methylxanthine-treated premature newborns. Sourgens H; Staib AH; Bielicki M; von Loewenich V Pediatr Pharmacol (New York); 1983; 3(3-4):267-72. PubMed ID: 6677876 [TBL] [Abstract][Full Text] [Related]
10. Theophylline affects sleep-wake state development in premature infants. Thoman EB; Davis DH; Raye JR; Philipps AF; Rowe JC; Denenberg VH Neuropediatrics; 1985 Feb; 16(1):13-8. PubMed ID: 3974797 [TBL] [Abstract][Full Text] [Related]
11. [A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders]. Möller JC; Austing A; Püst B; Kohl M; Reiss I; Iven H; Gortner L Klin Padiatr; 1999; 211(2):86-91. PubMed ID: 10407818 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of apnea crisis in premature infants with a loading dose of theophylline]. Pagani G; Raponi S; Petrone M Minerva Pediatr; 1979 Jan; 31(2):187-9. PubMed ID: 460075 [No Abstract] [Full Text] [Related]
13. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity. Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272 [TBL] [Abstract][Full Text] [Related]